| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000022341 |
| Receipt No. | R000025457 |
| Official scientific title of the study | A Multicenter, single-blind, randomized, parallel-group trial comparing Reinforced Reload with Tri-Staple with Tri-Staple during Distal Pancreatectomy |
| Date of disclosure of the study information | 2016/05/18 |
| Last modified on | 2019/02/05 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | A Multicenter, single-blind, randomized, parallel-group trial comparing Reinforced Reload with Tri-Staple with Tri-Staple during Distal Pancreatectomy | |
| Title of the study (Brief title) | RETTS-DP trial | |
| Region |
|
|
| Condition | ||
| Condition | Patients who underwent distal pancreatectomy | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate whetehr use of Reinforced Reload with Tri-Staple can significantly reduce the incidence of pancreatic fistula compared with Tri-Staple. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Incidence of Grade B/C postoperative pancreatic fistula within one month after surgery |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Single blind -participants are blinded |
| Control | Active |
| Stratification | YES |
| Dynamic allocation | YES |
| Institution consideration | Institution is considered as adjustment factor in dynamic allocation. |
| Blocking | NO |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Use of Reinforced Reload with Tri-Staple | |
| Interventions/Control_2 | Use of Tri-Staple | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1.Patients who underwent distal pancreatectomy
2.Performance Status(PS)is 0-1 of Eastern Cooperative Oncology Group(ECOG) 3.more than 20 years old 4.Patients without distant metastasis excepting for liver metastasis from neouroendcrine tumor 5.Patients whose function of main organs is maintained. 6.Patients who canunderstand the contents of this clinical trial |
|||
| Key exclusion criteria | 1.patients with severe ischemic heart disease(NYHA > III)
2.patients with grade C of liver damage 3.patients requred countiuous oxygen administration due to severe lung disease 4.patients who received dialysis 5.patients with active cancer disease that may influence perioerative adverse events. 6.Patients who enable to enroll this trial due to their mental illness. 7.Patients who reject to enroll this trial |
|||
| Target sample size | 120 | |||
| Research contact person | |
| Name of lead principal investigator | Yoshiaki Murakami |
| Organization | Hiroshima University Hospital |
| Division name | Gastrointestinal Surgery |
| Address | 1-2-3,KASUMI, MINAMI-KU, Hiroshima, JAPAN |
| TEL | 082-257-5215 |
| mura777@hiroshima-u.ac.jp | |
| Public contact | |
| Name of contact person | Naru Kondo |
| Organization | Hiroshima University Hospital |
| Division name | Gastrointestinal Surgery |
| Address | 1-2-3,KASUMI, MINAMI-KU, Hiroshima, JAPAN |
| TEL | 082-257-5215 |
| Homepage URL | |
| k-naru-surg@hiroshima-u.ac.jp | |
| Sponsor | |
| Institute | Hiroshima University Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | No |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 広島大学病院(広島県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025457 |